From phenotype-based to biology-driven screening for preterm birth risk: an expert European perspective.

Abstract excerpt

Preterm birth (PTB) remains a significant public health concern despite advances in obstetric and neonatal care. Risk screening methods have modest predictive power, primarily because they rely on clinical risk factors that are not present in most women who experience a PTB. Unlike a single disease entity, PTB is a heterogeneous syndrome caused by various genetic, clinical, and environmental factors, and...

Topics

Join the communities discussing this publication.

• Biomarkers
• Europe
• Infant, Newborn
• Phenotype
• Pregnancy